Stanford University School of Medicine, LPCH — Palo Alto, California

Stanford University School of Medicine, LPCH is a clinical research site located in Palo Alto, California, United States 94305.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University School of Medicine, LPCH has participated in 1 clinical trials.

Therapeutic areas: Epidermolysis Bullosa Dystrophica, Recessive, Epidermolysis Bullosa Dystrophica, Dominant.

Sponsors: Phoenicis Therapeutics.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University School of Medicine, LPCH?

Stanford University School of Medicine, LPCH has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University School of Medicine, LPCH conducted?

Stanford University School of Medicine, LPCH has 1 clinical trials on record. Their work covers Epidermolysis Bullosa Dystrophica, Recessive, Epidermolysis Bullosa Dystrophica, Dominant.

Is Stanford University School of Medicine, LPCH accredited by Crixeo Health?

Stanford University School of Medicine, LPCH has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University School of Medicine, LPCH?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.